Desloratadine - NDSRI's


Frequently Asked Questions

If unexpected Desloratadine impurities are detected, investigations can identify their sources, assess potential risks to patient safety, and implement corrective actions to prevent recurrence.

Some Desloratadine impurities may alter the bioavailability of Desloratadine, affecting its absorption, distribution, metabolism, and excretion in the body.

Safety measures during the storage of Desloratadine impurities include proper labeling, secure storage conditions, and regular monitoring for any signs of degradation.

Desloratadine impurities help in pharmaceutical research, product development, ANDA and DMF filing, quality control (QC), method validation, and stability studies.

Note: Products protected by valid patents by a manufacturer are not offered for sale in countries having patent protection. The sale of such products constitutes a patent infringement, and its liability is at the buyer's risk.

Back to Top
Product has been added to your cart